{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Orbai AM"],"funding":["Jerome L. Greene Foundation","Pfizer","National Institute for Health Research (NIHR)","NIAMS NIH HHS"],"pagination":["1772-1779"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7153974"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["72(12)"],"pubmed_abstract":["<h4>Objective</h4>Sex differences may modify symptoms, disease expression, and treatment effects. The objective of this study was to evaluate the link between life impact and sex in psoriatic arthritis (PsA).<h4>Methods</h4>Remission and Flare in Psoriatic Arthritis (ReFlaP; ClinicalTrials.gov identifier: NCT03119805) was a study in 14 countries of consecutive adult patients with definite PsA. Participants underwent comprehensive PsA assessment using the following measures: Disease Activity in Psoriatic Arthritis (DAPSA), Minimal Disease Activity (MDA), and Psoriatic Arthritis Impact of Disease (PsAID). Disease activity was compared by sex using t-tests or Wilcoxon tests. The association of PsAID with sex was analyzed using hierarchical generalized linear models.<h4>Results</h4>Of 458 part"],"journal":["Arthritis care & research"],"pubmed_title":["Determinants of Patient-Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association With Sex in 458 Patients From Fourteen Countries."],"pmcid":["PMC7153974"],"funding_grant_id":["Jerome L Greene Foundation Scholar","CL-2011-02-001","CS-2016-16-016","P30 AR070254"],"pubmed_authors":["Orbai AM","Kalyoncu U","Kiltz U","Dernis E","Scrivo R","Aydin S","Canete JD","Richette P","Perin J","Gorlier C","de Wit M","Coates LC","Palominos PE","Ruyssen-Witrand A","Eder L","Leung YY","Talli S","Smolen JS","Gaydukova I","Gossec L","Soubrier M","Lubrano E","Husni ME","Balanescu A"],"additional_accession":[]},"is_claimable":false,"name":"Determinants of Patient-Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association With Sex in 458 Patients From Fourteen Countries.","description":"<h4>Objective</h4>Sex differences may modify symptoms, disease expression, and treatment effects. The objective of this study was to evaluate the link between life impact and sex in psoriatic arthritis (PsA).<h4>Methods</h4>Remission and Flare in Psoriatic Arthritis (ReFlaP; ClinicalTrials.gov identifier: NCT03119805) was a study in 14 countries of consecutive adult patients with definite PsA. Participants underwent comprehensive PsA assessment using the following measures: Disease Activity in Psoriatic Arthritis (DAPSA), Minimal Disease Activity (MDA), and Psoriatic Arthritis Impact of Disease (PsAID). Disease activity was compared by sex using t-tests or Wilcoxon tests. The association of PsAID with sex was analyzed using hierarchical generalized linear models.<h4>Results</h4>Of 458 part","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Dec","modification":"2026-05-02T11:45:39.204Z","creation":"2022-02-11T13:21:45.134Z"},"accession":"S-EPMC7153974","cross_references":{"pubmed":["31609525"],"doi":["10.1002/acr.24090"]}}